Rao, Reena <br/><br/>
Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.  [electronic resource] 

 -  American journal of physiology. Renal physiology  Apr 2005 
 - F642-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1931-857X 
<br/><br/><label>Standard No.: </label>10.1152/ajprenal.00287.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Cells, Cultured<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Diabetes Insipidus--chemically induced<br/>Dinoprostone--urine<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Kidney Medulla--cytology<br/>Lithium Chloride--pharmacology<br/>Male<br/>Membrane Proteins<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Mutant Strains<br/>Microsomes--drug effects<br/>Osmolar Concentration<br/>Polyuria--chemically induced<br/>Prostaglandin-Endoperoxide Synthases--genetics<br/>Rats<br/>Rats, Brattleboro